CELU
Price:
$0.7523
Market Cap:
$18.10M
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing t...[Read more]
Industry
Biotechnology
IPO Date
2019-08-08
Stock Exchange
NASDAQ
Ticker
CELU
According to Celularity Inc.’s latest financial reports and current stock price. The company's current ROE is 411.46%. This represents a change of 159.68% compared to the average of 158.45% of the last 4 quarters.
The mean historical ROE of Celularity Inc. over the last ten years is -281.54%. The current 411.46% ROE has changed -246.15% with respect to the historical average. Over the past ten years (40 quarters), CELU's ROE was at its highest in in the March 2025 quarter at 358.77%. The ROE was at its lowest in in the September 2020 quarter at -344.40%.
Average
-281.54%
Median
-127.20%
Minimum
-1112.77%
Maximum
241.19%
Discovering the peaks and valleys of Celularity Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 624.03%
Maximum Annual ROE = 241.19%
Minimum Annual Increase = -17715.22%
Minimum Annual ROE = -1112.77%
| Year | ROE | Change |
|---|---|---|
| 2025 | 241.19% | -136.82% |
| 2024 | -655.11% | 36.70% |
| 2023 | -479.24% | -6816.49% |
| 2022 | 7.14% | -107.09% |
| 2021 | -100.70% | -90.95% |
| 2020 | -1112.77% | 624.03% |
| 2019 | -153.69% | -17715.22% |
The current ROE of Celularity Inc. (CELU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-297.72%
5-year avg
-197.35%
10-year avg
-281.54%
Celularity Inc.’s ROE is less than BioAtla, Inc. (166.67%), greater than Reviva Pharmaceuticals Holdings, Inc. (-220.39%), greater than Annovis Bio, Inc. (-318.08%), greater than FibroGen, Inc. (-234.28%), greater than Actinium Pharmaceuticals, Inc. (-218.67%), less than BioXcel Therapeutics, Inc. (75.79%), greater than Kezar Life Sciences, Inc. (-58.35%), greater than PolyPid Ltd. (-241.96%), greater than Tempest Therapeutics, Inc. (-729.89%), greater than Generation Bio Co. (-94.82%),
| Company | ROE | Market cap |
|---|---|---|
| 166.67% | $4.61M | |
| -220.39% | $2.08M | |
| -318.08% | $34.43M | |
| -234.28% | $36.69M | |
| -218.67% | $32.32M | |
| 75.79% | $37.05M | |
| -58.35% | $53.86M | |
| -241.96% | $48.30M | |
| -729.89% | $5.46M | |
| -94.82% | $35.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Celularity Inc.'s ROE?
How is the ROE calculated for Celularity Inc. (CELU)?
What is the highest ROE for Celularity Inc. (CELU)?
What is the 3-year average ROE for Celularity Inc. (CELU)?
What is the 5-year average ROE for Celularity Inc. (CELU)?
How does the current ROE for Celularity Inc. (CELU) compare to its historical average?